Transcatheter MitraClip repair alters mitral annular geometry - device induced annular remodeling on three-dimensional echocardiography predicts therapeutic response

• Published in: Cardiovascular ultrasound Vol. 17; no. 1; p. 31
• Main Authors: Kim, Jiwon, Palumbo, Maria Chiara, Khalique, Omar K, Rong, Lisa Q, Sultana, Razia, Das, Mukund, Jantz, Jennifer, Nagata, Yasfumi, Devereux, Richard B, Wong, Shing Chiu, Bergman, Geoffrey W, Levine, Robert A, Ratcliffe, Mark B, Weinsaft, Jonathan W
• Format: Journal Article
• Language: English
• Published: England BioMed Central 26-12-2019; BMC
• Subjects: 3D echocardiography; Aged; Aged, 80 and over; Automation; Cardiac Catheterization - methods; Circumferences; Decision making; Diagnostic systems; Diameters; Echocardiography; Echocardiography, Three-Dimensional; Female; Heart; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation - methods; Humans; Male; MitraClip; Mitral annulus; Mitral Valve - diagnostic imaging; Mitral Valve - surgery; Mitral Valve Insufficiency - diagnostic imaging; Mitral Valve Insufficiency - surgery; Multivariate analysis; Patients; Population; Population studies; Pulmonary arteries; Reduction; Studies; Variables; Ventricle; MitraClip; Mitral annulus; 3D echocardiography
• DOI: 10.1186/s12947-019-0181-z
• EISSN: 1476-7120

Echocardiography (echo) is widely used to guide therapeutic decision-making for patients being considered for MitraClip. Relative utility of two- (2D) and three-dimensional (3D) echo predictors of MitraClip response, and impact of MitraClip on mitral annular geometry, are uncertain.
The study population comprised patients with advanced (> moderate) MR undergoing MitraClip. Mitral annular geometry was quantified on pre-procedural 2D transthoracic echocardiography (TTE) and intra-procedural 3D transesophageal echocardiography (TEE); 3D TEE was used to measure MitraClip induced changes in annular geometry. Optimal MitraClip response was defined as ≤mild MR on follow-up (mean 2.7 ± 2.5 months) post-procedure TTE.
Eighty patients with advanced MR underwent MitraClip; 41% had optimal response (≤mild MR). Responders had smaller pre-procedural global left ventricular (LV) end-diastolic size and mitral annular diameter on 2D TTE (both p ≤ 0.01), paralleling smaller annular area and circumference on 3D TEE (both p = 0.001). Mitral annular size yielded good diagnostic performance for optimal MitraClip response (AUC 0.72, p < 0.01). In multivariate analysis, sub-optimal MitraClip response was independently associated with larger pre-procedural mitral annular area on 3D TEE (OR 1.93 per cm
/m
[CI 1.19-3.13], p = 0.007) and global LV end-diastolic volume on 2D TTE (OR 1.29 per 10 ml/m
[CI 1.02-1.63], p = 0.03). Substitution of 2D TTE derived mitral annular diameter for 3D TEE data demonstrated a lesser association between pre-procedural annular size (OR 5.36 per cm/m
[CI 0.95-30.19], p = 0.06) and sub-optimal MitraClip response. Matched pre- and post-procedural TEE analyses demonstrated MitraClip to acutely decrease mitral annular area and circumference (all p < 0.001) as well as mitral tenting height, area, and volume (all p < 0.05): Magnitude of MitraClip induced reductions in mitral annular circumference on intra-procedural 3D TEE was greater among patients with, compared to those without, sub-optimal MitraClip response (>mild MR) on followup TTE (p = 0.017); greater magnitude of device-induced annular reduction remained associated with sub-optimal MitraClip response even when normalized for pre-procedure annular circumference (p = 0.028).
MitraClip alters mitral annular geometry as quantified by intra-procedural 3D TEE. Pre-procedural mitral annular dilation and magnitude of device-induced reduction in mitral annular size on 3D TEE are each associated with sub-optimal therapeutic response to MitraClip.